Mass Innovation Labs is the premier laboratory work space and accelerated commercialization solution in the life sciences sphere.
Our member companies are working on breakthroughs that will change the lives of millions of patients around the globe. We invite you to join the global life sciences revolution and accelerate your discovery process.
Research requires significant resources, and our member companies have already raised more than $4 billion of investment capital. Just another benefit of the Mass Innovation Labs paradigm.
The turn-key operational support from Mass Innovation Labs enabled us to get up and running quickly, expand our team, and focus on hitting key milestones as we make headway on our breakthrough approach in gene-editing CRISPR-Cas-9.
Dr. Bill Lundberg, Chief Scientific Officer of CRISPR Therapeutics
Mass Innovation Labs provides an ideal space within the leading scientific community of Kendall Square for us to conduct our research. They make it possible to reduce the standard start-up time by several months, supporting rapid initiation of our research program to bring personalized cancer immunotherapies to patients. Having the ability to work so quickly is like being able to buy time.
Andrew Allen, M.D., Ph.D, Co-founder, President, and CEO of Gritstone Oncology
Mass Innovation Labs isn't just an incubator. It accelerates your effort. It saves a significant amount of time. When we started here, it was really just two men and a molecule. Within two weeks of opening our doors here we had equipment and permits ready to actually do work.
Ron Seidel, Co-founder, Executive VP, and Head of Research and Development of Cue Biopharma